» Articles » PMID: 35869660

HCV Point of Care Screening in People Tested for SARS-CoV-2 in a Social-housing Neighbourhood of Milan, Italy

Overview
Journal Liver Int
Specialty Gastroenterology
Date 2022 Jul 23
PMID 35869660
Authors
Affiliations
Soon will be listed here.
Citing Articles

Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study.

Aghemo A, Persico M, DAmbrosio R, Andreoni M, Villa E, Bhagat A PLoS One. 2023; 18(2):e0280165.

PMID: 36730135 PMC: 9894491. DOI: 10.1371/journal.pone.0280165.